Dr. James E. Mossell III, DO

Dr. Mossell practices at Tift Regional Medical Center in Tifton, Georgia, part of Southwell.

Dr. Mossell's NPI, 1720195837, was assigned on August 24, 2006. Dr. Mossell graduated from New York College of Osteo Medicine of New York Institute of Technology in 1989. Dr. Mossell holds Georgia license 044028.

Dr. Mossell's primary practice is Tift Regional Medical Center, at 901 E 18th Street, Tifton, GA 31794 in Tift County. The practice phone is (229) 382-7120.

Dr. Mossell's primary practice is Tift Regional Medical Center in Tifton, Georgia, part of Southwell. Dr. Mossell is also affiliated with Colquitt Regional Medical Center. The medical group on file is Tift Regional Health System. Dmand AI also links Dr. Mossell to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 breast imaging center, each named with a free account. Dr. Mossell's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mossell practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mossell's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Mossell is licensed in Georgia.

CMS data shows 6,293 Medicare services from Dr. Mossell across 10 procedure codes in 2024, for 445 Medicare patients. Medicare paid $146,429 for them. Every service was in an office.

CMS counts 445 Medicare patients who saw Dr. Mossell in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have arthritis, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mossell's median patient age at 69, with 83% women.

In 2024, Dr. Mossell wrote 9,661 Medicare Part D claims for 937 patients. 85% of them were for generic drugs. CMS names the drug for 9,145 of them, across 111 drugs with 11 or more claims each, at $8,572,430 in total drug cost. In 2023, CMS named 10,039 claims across 115 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Mossell for performance year 2024, reported as part of a group. Dr. Mossell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mossell as offering telehealth.

Dmand AI links 3 papers to Dr. Mossell, published from 2016 to 2022. Dr. Mossell's most frequent co-authors are Joel M. Kremer, MD and Dimitrios Pappas, MD.

CMS Open Payments shows 4,342 general payments to Dr. Mossell from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Abbvie Inc. paid the most, $470,779.

Dr. Mossell graduated from New York College of Osteo Medicine of New York Institute of Technology in 1989.